Zied Ferjaoui

Dr. Zied Ferjaoui

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2019 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
Zied FerjaouiZied Ferjaoui
Zied Ferjaoui
EDEnaam Jamal Al Dine
Enaam Jamal Al Dine
AKAigul Kulmukhamedova
Aigul Kulmukhamedova
LBLina Bezdetnaya
Lina Bezdetnaya
CCCrosby Soon Chang
Crosby Soon Chang
HAHalima Alem
Halima Alem

8 July 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
Zied FerjaouiZied Ferjaoui
Zied Ferjaoui
JLJose Roberto López
Jose Roberto López
SASoheil Akbari
Soheil Akbari
FCFatiha Chandad
Fatiha Chandad
DMDiego Mantovani
Diego Mantovani
RFRoberto D. Fanganiello
Roberto D. Fanganiello
Alginate/gelatin (Alg-Gel) hydrogels have been used experimentally, associated with mesenchymal stromal/stem cells (MSCs), to guide bone tissue formation. One of the main challenges for clinical application is optimizing Alg-Gel stiffness to guide osteogenesis. In this study, we investigated how Alg-Gel stiffness could modulate the dental pulp stem cell (DPSC) attachment, morphology, proliferation, and osteogenic differentiation, identifying the optimal conditions to uncouple osteogenesis from the other cell behaviors. An array of Alg-Gel hydrogels was prepared by casting different percentages of alginate and gelatin cross-linked with 2% CaCl2. We have selected two hydrogels: one with a stiffness of 11 ± 1 kPa, referred to as “low-stiffness hydrogel”, formed by 2% alginate and 8% gelatin, and the other with a stiffness of 55 ± 3 kPa, referred to as “high-stiffness hydrogel”, formed by 8% alginate and 12% gelatin. Hydrogel analyses showed that the average swelling rates were 20 ± 3% for the low-stiffness hydrogels and 35 ± 2% for the high-stiffness hydrogels. The degradation percentage was 47 ± 5% and 18 ± 2% for the low- and high-stiffness hydrogels, respectively. Both hydrogel types showed homogeneous surface shape and protein (Alg-Gel) interaction with CaCl2 as assessed by physicochemical characterization. Cell culture showed good adhesion of the DPSCs to the hydrogels and proliferation. Furthermore, better osteogenic activity, determined by ALP activity and ARS staining, was obtained with high-stiffness hydrogels (8% alginate and 12% gelatin). In summary, this study confirms the possibility of characterizing and optimizing the stiffness of Alg-Gel gel to guide osteogenesis in vitro without altering the other cellular properties of DPSCs.

1 November 2017 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
EDEnaam Jamal Al Dine
Enaam Jamal Al Dine
Zied FerjaouiZied Ferjaoui
Zied Ferjaoui
JGJaafar Ghanbaja
Jaafar Ghanbaja
TRThibault Roques-Carmes
Thibault Roques-Carmes
AMAbdelaziz Meftah
Abdelaziz Meftah
HAHalima Alem
Halima Alem

24 May 2024 in Advanced Engineering Materials
Verified
Journal Article
Open access
Zied FerjaouiZied Ferjaoui
Zied Ferjaoui
JLJose Roberto López
Jose Roberto López
SASoheil Akbari
Soheil Akbari
HIHawraa Issa
Hawraa Issa
ASAbdelhabib Semlali
Abdelhabib Semlali
RFRoberto Fanganiello
Roberto Fanganiello
Bone tissue engineering relies on crucial scaffolds for tissue formation and stem cell differentiation. A composite scaffold of alginate‐gelatin effectively supports these processes. This study aims to design a porous alginate‐gelatin hydrogel and assess pore size effects on cell behavior, focusing on morphology, adhesion, and proliferation in distinct osteogenic environments. Hydrogels are prepared using various alginate‐gelatin concentrations: 4% alginate and 6% gelatin (4A6G) or 3% alginate and 5% gelatin (3A5G), cross‐linked with 2% CaCl2. Pore size optimization employs simple freezing and thawing cycles. Scanning electron microscopy reveals varying pore sizes: 340 µm ± 30 µm for 4A6G and 635 µm ± 25 µm for 3A5G. Stiffness measurements indicate significant differences: ≈26.3 kPa ± 0.6 KPa for 4A6G and 21.6 kPa ± 0.2 KPa for 3A5G. Cell interaction studies demonstrate higher adhesion and proliferation rates in larger‐pored hydrogels. Evaluation of bone tissue formation, including RT‐PCR, ALP activity, and ARS staining, reveal superior osteogenic potential in the 3A5G hydrogel compared to 4A6G. In conclusion, the 3A5G hydrogel (3% alginate and 5% gelatin) holds promise for bone tissue regeneration due to its biodegradability and favorable bone‐forming properties.

17 May 2017 in RSC Advances
Verified
Journal Article
Open access
PDF file
Zied FerjaouiZied Ferjaoui
Zied Ferjaoui
Raphaël SchneiderRaphaël Schneider
Raphaël Schneider
AMAbdelaziz Meftah
Abdelaziz Meftah
Eric GAFFETEric GAFFET
Eric GAFFET
HAHalima Alem
Halima Alem
The preparation of responsive superparamagnetic iron oxide (SPIO) nanoparticles (NPs), able to carry the anticancer drug doxorubicin (DOX) and to release it in physiological media at the physiological temperature, is one of the major challenges in nanomedicine. In this work, two families of NPs were synthesized. The first one consists of superparamagnetic Fe3O4 NPs functionalized via covalent grafting by a biocompatible responsive copolymer based on 2-(2-methoxy)ethyl methacrylate (MEO2MA) and oligo(ethylene glycol) methacrylate (OEGMA). The second one consists of the same core/shell NPs but folic acid, a biological cancer targeting molecule, was grafted at the polymer chain end. The core/shell NPs were fully characterized by the combination of spectroscopic and microscopic techniques. The influence of the polymer chain structure in water and in physiological media was studied. We demonstrate that the magnetic properties of the NPs were only influenced by the amount of the grafted polymer and no influence of NP aggregation was evidenced. Indeed, the derived nanostructured materials displayed a combination of the physical properties of the core and the macromolecular behavior of the shell. The drug release experiments confirmed that DOX was largely released above the co-polymer LCST due to the presence of DOX. The nanomaterials developed in this work have high potential as multi-modal cancer therapy tools.

17 January 2025 in Advanced Optical Materials
Verified
Journal Article
Open access
Zied FerjaouiZied Ferjaoui
Zied Ferjaoui
CMCelina Matuszewska
Celina Matuszewska
JLJianhua Liu
Jianhua Liu
YCYohann Corvis
Yohann Corvis
CCCorinne Chanéac
Corinne Chanéac
CRCyrille Richard
Cyrille Richard
A new method is presented for the in vitro detection of glucose using glucose oxidase (GOx) covalently linked to persistent luminescent nanoparticles (PLNPs). This method ensures both sensitive and specific glucose detection by exploiting the enhanced luminescence of PLNPs in the presence of H 2 O 2 , generated by an enzymatic reaction. To this end, three different PLNPs composed of ZnGa 2 O 4 :Cr 3+ (ZGO) nanoparticles are prepared by hydrothermal synthesis at 120 °C for 6 h (ZGO1), 12 h (ZGO2), and 24 h (ZGO3), followed by a calcination at 500 °C, resulting in nanoparticles with an average hydrodynamic diameter of 100 nm ± 5 nm after grinding and centrifugation. These nanoparticles are efficiently covalently functionalized with GOx, via a PEG linker. Following the production of H 2 O 2 by the enzymatic reaction between GOx bound to the ZGO surface and glucose present in 100‐fold diluted serum, a significant increase in the persistent luminescent signal is observed. This phenomenon is most pronounced for ZGO2, for which a detection limit of 0.01 µ m and a detection range from 0.05 to 1 µ m is obtained. These results demonstrate the innovative potential of this new technique in glucose monitoring, opening up new avenues for real‐time monitoring and effective management of diabetes.